外傷性脊髄損傷:治療薬の治験動向(2014年下半期)

◆英語タイトル:Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2291CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年8月12日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥530,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥795,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014″ provides data on the Traumatic Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Traumatic Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Traumatic Spinal Cord Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Traumatic Spinal Cord Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Traumatic Spinal Cord Injury 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Traumatic Spinal Cord Injury Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Stem Cell Sciences UK Ltd 28
Clinical Trial Overview of Stem Cell Sciences UK Ltd 28
NuVasive, Inc. 29
Clinical Trial Overview of NuVasive, Inc. 29
AOSpine International 30
Clinical Trial Overview of AOSpine International 30
Acorda Therapeutics, Inc. 31
Clinical Trial Overview of Acorda Therapeutics, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
Simon Fraser University 32
Clinical Trial Overview of Simon Fraser University 32
Tehran University of Medical Sciences 33
Clinical Trial Overview of Tehran University of Medical Sciences 33
Shanghai Changzheng Hospital 34
Clinical Trial Overview of Shanghai Changzheng Hospital 34
Christian Medical College 35
Clinical Trial Overview of Christian Medical College 35
Indian Council of Medical Research 36
Clinical Trial Overview of Indian Council of Medical Research 36
Rennes University Hospital 37
Clinical Trial Overview of Rennes University Hospital 37
Yonsei University 38
Clinical Trial Overview of Yonsei University 38
Capital District Health Authority, Canada 39
Clinical Trial Overview of Capital District Health Authority, Canada 39
Hadassah Medical Organization 40
Clinical Trial Overview of Hadassah Medical Organization 40
University of Miami 41
Clinical Trial Overview of University of Miami 41
Five Key Clinical Profiles 42
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region, 2014* 7
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Traumatic Spinal Cord Injury Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Stem Cell Sciences UK Ltd, 2014* 28
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by NuVasive, Inc., 2014* 29
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AOSpine International, 2014* 30
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 31
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Simon Fraser University, 2014* 32
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 33
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2014* 34
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, 2014* 35
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2014* 36
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2014* 37
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 38
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2014* 39
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 40
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 41

List of Figures
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 57

【レポートのキーワード】

外傷性脊髄損傷、治療、薬、医薬品、治験、臨床試験

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[外傷性脊髄損傷:治療薬の治験動向(2014年下半期)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆